Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET

Background: Brain imaging measurements can provide evidence of possible preclinical Alzheimer’s disease (AD). Their ability to predict individual imminent clinical conversion remains unclear.